Skip to content
Therapy But Better – Lifestyle
Author:
Acrivon Therapeutics, Inc
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2026
Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts
May 14, 2026
←
Previous Page
1
2